Table 2.
Summary of the toxicological studies on the adverse health effects of ambient UFPs.
| Targeting system | PM source or material | Particle size | Animal model | Exposure method | Effect | Potential toxicological mechanisms | Reference |
|---|---|---|---|---|---|---|---|
| Respiratory system |
Ambient sampling | 188 nm (average) | BALB/c mice | Nasal instillation | Chronic pneumonia | Il-6, Il-1b, Il-10 increase Cyp1a1, Cyp1b1 increase |
[10] |
| CuO NPs | 200 nm (average) | C57BL/6 mice | Intratracheal instillation | Acute lung injury | T cell subset imbalance | [134] | |
| CB NPs | 40 nm (average) | C57BL/6 mice | Whole-body exposure | Small airway obstruction | CC16 decrease SP-A increase |
[135] | |
| Ambient sampling |
50 nm (average) |
C57BL/6 mice BALB/c mice |
Whole-body exposure |
Offspring pulmonary immunosuppression |
Th2-driven pulmonary inflammation decrease |
[19] |
|
| Cardiovascular system |
DEP | 24 nm (average) | Rat cardiomyocytes | Cellular contamination | Cardiomyocyte dysfunction | The reduction in contractility and calcium handling in cardiomyocytes | [36] |
| Ambient sampling | <100 nm | Sprague Dawley rat | Intratracheal instillation | Cardiac I/R injury | mPTP Ca2+ Sensitization | [136] | |
| Ambient sampling | 76 nm (average) | C57BL/6 mice | Whole-body exposure | Cardiac arrhythmias | GTR decrease Cardiac contractility decrease |
[29] | |
| Ambient sampling | <60 nm | C57BL/6 mice | Intratracheal instillation | Offspring hypertension | Alterations in methylation of promoter regions of RAS-related elements | [33] | |
| Road traffic | <180 nm | ApoE−/− mice | Whole-body exposure | Atherosclerosis | Activates the Nrf2 signaling | [34] | |
| Road traffic | 45 nm (average) | Ldlr−/− mice | Whole-body exposure | Vascular calcification | Activates the NF-κB signaling | [37] | |
| Road traffic | 45 nm (average) | Ldlr−/− mice | Whole-body exposure | Atherosclerosis | Lipid metabolism and HDL dysfunction | [35] | |
| Ambient sampling |
<100 nm |
C57BL/6 mice |
Thoracic aorta exposure |
Impaired vasomotor responses |
Oxidative stress Loss of anti-oxidant defenses |
[137] |
|
| Digestive system |
CB NPs | 100 nm (average) | C57BL/6 mice | Oral administration | Acute hepatitis | ROS, CAT increase | [42] |
| CB NPs | 51 nm (average) | C57BL/6 mice hepatocytes | Cellular contamination | Hepatocytes apoptosis | ROS increase Lipid peroxidation increase |
[44] | |
| CB NPs | 35 nm (average) | C57BL/6 mice | Intravenous injection | Hepatic genotoxicity | Oxidative DNA damage | [47] | |
| Road traffic | 82 nm (average) | Ldlr-null mice | Whole-body exposure | Gastrointestinal inflammation | The levels of oxidized fatty acids and LPA in intestine increase | [50] | |
| Road traffic | 45 nm (average) | Ldlr−/− mice | Oral administration | Intestinal microbial composition disorders | LPC 18:1 level increase | [51] | |
| Ambient sampling |
66 nm (average) |
C57BL/6 mice |
Whole-body exposure |
Lipid metabolism disorders |
Activate the FXR/LXR and Hnf4a signaling |
[52] |
|
| Central nervous system | Ambient sampling | Natural occurreda | C57BL/6 mice | Whole-body exposure | AD | Amyloid deposition, tangles, and plaque increase | [54] |
| Fuel combustion | 178 nm (average) | C57BL/6 mice | Whole-body exposure | AD | Perturbation in hippocampal redox homeostasis | [59] | |
| Road traffic | 83 nm (average) | 3xTgAD mice | Whole-body exposure | AD | Neuroinflammation | [60] | |
| BB and DEP | <50 nm | BALB/c mice | Intratracheal instillation | Neurodegeneration | HO-1, Hsp70, Cyp1b1 increase iNOS, COX-2 increase | [62] | |
| Diesel Exhaust | <100 nm | Fischer rats | Whole-body exposure | Neuroinflammation | TNFα, α Synuclein, Aβ42 increase Tau hyperphosphorylation |
[63] | |
| Ambient sampling | Natural occurreda | B6C3F1 hybrid mice | Whole-body exposure | Neurodevelopmental disorders | Enlarged brain ventricles, increased corpus callosum area, decreased hippocampal | [64] |
Aβ42, β-amyloid (1–42); BB, biomass burning-derived; CC16, clara cell secretory protein; COX-2, cyclooxygenase 2; Cyp1b1, Cytochrome P450 1b1; DEP, diesel exhaust particles; FXR, farnesoid X receptor; GTR, glutathione S-transferase; Hnf4a, hepatocyte nuclear factor 4 alpha; HO-1, heme oxygenase-1; Hsp70, heat-shock protein 70; I/R, cardiac ischemia/reperfusion; iNOS, inducible nitric oxide synthase; LPA, lysophosphatidic acids; LPC 18:1, lysophosphatidylcholine; LXR, liver X receptor; mPTP, mitochondrial permeability transition pore; RAS, renin-angiotensin system; SP-A, lung surface viability protein A; Tau, microtubule-associated protein tau; TNFα, tumor necrosis factor-α.
Particle size is not presented in this study.